View Clinical Trial (Medical Research Study)
Increasing Hepatitis B Screening Among Korean Church Attendees (Component Project) Program Project Title: Liver Cancer Control Interventions for Asian Americans
| City: |
|
Los Angeles |
| State: |
|
California |
| Zip Code: |
|
90095 |
| Conditions: |
|
Hepatitis B |
| Purpose: |
|
The purpose of this study is to design an intervention to increase hepatitis B (HBV)
screening among Korean Americans.
The investigators will design a culturally specific intervention; an educational small group
discussion led by a trained Korean leader. The effect of the intervention will be tested on
1200 Korean Americans.
Subjects will be recruited at Korean churches and invited to join a one-hour discussion of
health issues with other members of their church. One half of the subjects will participate
in the intervention group. These subjects will discuss HBV and will receive resources
related to HBV and where to obtain screening. The other half of the subjects will
participate in the control group. These subjects will discuss nutrition and physical
activity and will receive resources related to these topics, but not related to HBV and
where to obtain screening.
All subjects will be interviewed before the sessions and 6 months after the sessions to
assess HBV screening levels in the two groups. Self-reported HBV screening will be verified
by a review of subjects' medical records.
The primary study hypothesis is that the intervention group will have a higher rate of HBV
serologic testing at follow-up compared to the control group.
Secondary hypotheses are:
The intervention group will have a higher level of knowledge of hepatitis B and liver cancer
at follow-up compared to the control group.
The effect of the intervention on hepatitis B serologic testing will be mediated by
knowledge of hepatitis B and liver cancer.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Korean ancestry
- Have not previously received HBV screening or do not know the results of previous HBV
screening test
- No history of liver cancer or liver disease
- Current resident of the Los Angeles area
Exclusion Criteria:
- Younger than 18 years of age or Older than 64 years of age
- Not of Korean ancestry
- Previously screened for HBV
- History of liver disease or liver cancer
- Not a current resident of the Los Angeles area
|
| NCT ID: |
|
NCT00760721 |
| Primary Contact: |
|
Principal Investigator
Roshan Bastani, PhD
University of California, Los Angeles
Roshan Bastani, PhD
Phone: 310-206-9266
Email: bastani@ucla.edu
|
| Backup Contact: |
|
Email: bglenn@ucla.edu
Beth A Glenn, PhD
Phone: 310-206-9715
|
| Location Contact: |
|
Los Angeles, California 90095
United States
Alison K Herrmann, MS
Phone: 310-206-8483
Email: aherrmann@ucla.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|